Hedge Funds Aren’t Crazy About GlaxoSmithKline plc (ADR) (NYSE:GSK) Anymore

GlaxoSmithKline plc (ADR) (NYSE:GSK) shareholders have witnessed a decrease in hedge fund interest recently.

GlaxoSmithKline plc (ADR) (NYSE:GSK)

If you’d ask most market participants, hedge funds are assumed to be slow, outdated investment vehicles of yesteryear. While there are over 8000 funds trading at present, we at Insider Monkey hone in on the leaders of this club, around 450 funds. Most estimates calculate that this group has its hands on the lion’s share of the hedge fund industry’s total capital, and by watching their top picks, we have revealed a number of investment strategies that have historically outstripped the market. Our small-cap hedge fund strategy outstripped the S&P 500 index by 18 percentage points per annum for a decade in our back tests, and since we’ve started sharing our picks with our subscribers at the end of August 2012, we have trumped the S&P 500 index by 25 percentage points in 6.5 month (see all of our picks from August).

Equally as important, positive insider trading activity is a second way to parse down the stock market universe. Obviously, there are plenty of stimuli for an executive to cut shares of his or her company, but just one, very simple reason why they would behave bullishly. Several academic studies have demonstrated the market-beating potential of this tactic if investors understand where to look (learn more here).

Keeping this in mind, we’re going to take a gander at the key action regarding GlaxoSmithKline plc (ADR) (NYSE:GSK).

How have hedgies been trading GlaxoSmithKline plc (ADR) (NYSE:GSK)?

At the end of the fourth quarter, a total of 16 of the hedge funds we track held long positions in this stock, a change of -6% from the previous quarter. With hedgies’ positions undergoing their usual ebb and flow, there exists a select group of key hedge fund managers who were upping their stakes meaningfully.

When looking at the hedgies we track, Ken Fisher’s Fisher Asset Management had the most valuable position in GlaxoSmithKline plc (ADR) (NYSE:GSK), worth close to $467 million, accounting for 1.3% of its total 13F portfolio. On Fisher Asset Management’s heels is Arrowstreet Capital, managed by Peter Rathjens, Bruce Clarke and John Campbell, which held a $157 million position; 1.3% of its 13F portfolio is allocated to the company. Other hedge funds with similar optimism include Jim Simons’s Renaissance Technologies, Bill Miller’s Legg Mason Capital Management and Warren Buffett’s Berkshire Hathaway.

Since GlaxoSmithKline plc (ADR) (NYSE:GSK) has witnessed bearish sentiment from the aggregate hedge fund industry, logic holds that there is a sect of hedgies that decided to sell off their full holdings at the end of the year. It’s worth mentioning that Richard Driehaus’s Driehaus Capital dropped the biggest investment of the “upper crust” of funds we watch, totaling about $5 million in stock.. Bart Baum’s fund, Ionic Capital Management, also cut its call options., about $2 million worth. These bearish behaviors are important to note, as total hedge fund interest was cut by 1 funds at the end of the year.

What have insiders been doing with GlaxoSmithKline plc (ADR) (NYSE:GSK)?

Insider purchases made by high-level executives is particularly usable when the company in question has experienced transactions within the past 180 days. Over the last 180-day time period, GlaxoSmithKline plc (ADR) (NYSE:GSK) has experienced zero unique insiders purchasing, and zero insider sales (see the details of insider trades here).

With the results shown by our research, everyday investors must always watch hedge fund and insider trading activity, and GlaxoSmithKline plc (ADR) (NYSE:GSK) applies perfectly to this mantra.

Click here to learn more about Insider Monkey’s Hedge Fund Newsletter

Insider Monkey’s small-cap strategy returned 29.2% between September 2012 and February 2013 versus 8.7% for the S&P 500 index. Try it now by clicking the link above.

Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Largest Pharmaceutical Companies In the World

The 10 Most Expensive Android Apps

The 9 Most Expensive Designer Bags in the World

The 7 Most Expensive Real Estate in the World

The 10 Most Expensive eBay Items Ever Sold

The 10 Most Expensive iPhone Apps

The 9 Most Expensive Designer Shoes in the World

The 10 Most Expensive Cigarette Brands

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!